glp 1 triple agonist LY3437943, a novel glucagon, GIP, and GLP-1 receptor for glycemic control and weight loss: From discovery to clinical proof of concept: Cell Metabolism Retatrutide: The Next Generation of

Oncotarget 6 , 1182011832 (2015)

The risk reduction of SUD by 20% and even greater reduction of hospital and ED service will further change the cost-benefit equation significantly

This review provides an analysis of GLP-1 RAs and their multi-agonist derivatives as therapeutic agents for MASLD, examining their biological mechanisms and clinical efficacy based on current evidence

These SCFAs are like the start button for GLP-1 release

Abstract This study has been initiated to investigate whether sunitinib (SUN) alters the expression of key genes engaged in mitochondrial transport and oxidation of long chain fatty acids (LCFA), and if so, whether these alterations should be viewed as a mechanism of SUN-induced cardiotoxicity, and to explore the molecular mechanisms whereby carnitine supplementation could attenuate SUN-induced cardiotoxicity

A large randomized placebo-controlled trial observed significant metabolic improvements and behavioral gains in children taking a comprehensive vitamin/mineral supplement